具有糖、脂代谢调节活性的中药及其质量控制研究进展

doi:10.14088/j.cnki.issn0439-8114.2022.19.019

摘要/Abstract

摘要： 近年来糖、脂代谢紊乱疾病发病率有所上升,具有补益肝肾、利湿化痰作用的中药和中成药对其有明显的改善作用。中药质量是保证中药安全性、有效性的关键,传统质量控制手段包括一测多评和定量指纹图谱,质量标志物这一概念的提出为中药质量控制、用药安全有效提供了研究思路。对具有糖、脂代谢紊乱调节活性的单味中药、中药复方和中成药以及其质量控制研究进展进行了综述,为中药产品深层次开发提供了参考依据。

关键词: 中药, 糖、脂代谢紊乱, 质量控制研究

Abstract: In recent years, the incidence rate of disorders of glucose and lipid metabolism has increased, and traditional Chinese medicine and Chinese patent medicine with the functions of nourishing the liver and kidney, promoting dampness and resolving phlegm have significantly improved them. The quality of traditional Chinese medicine is the key to ensuring the safety and effectiveness of traditional Chinese medicine. The traditional quality control means include quantitative analysis of multi-components by single-marker and quantitative fingerprint. The concept of quality markers provides a research idea for the quality control of traditional Chinese medicine and the safety and effectiveness of drug use. The research progress of single traditional Chinese medicine, compound traditional Chinese medicine and Chinese patent medicine with regulating activity of glucose and lipid metabolism disorders was reviewed to provide a reference for the further development of traditional Chinese medicine products.

Key words: traditional Chinese medicine, disorders of saccharides and lipids metabolism, quality control

中图分类号:

R282.7

张铮洋, 陶雅婷, 李静平, 杨兴鑫, 俞捷. 具有糖、脂代谢调节活性的中药及其质量控制研究进展[J]. 湖北农业科学, 2022, 61(19): 97-104.

ZHANG Zheng-yang, TAO Ya-ting, LI Jing-ping, YANG Xing-xin, YU Jie. Research advances of traditional Chinese medicine with saccharides and lipids metabolism regulating activities and its quality control[J]. HUBEI AGRICULTURAL SCIENCES, 2022, 61(19): 97-104.

参考文献

[1] 国家卫生和计划生育委员会.中国卫生和计划生育统计年鉴[M].北京:中国协和医科大学出版社,2019.
[2] 陈萍,谭书明,陈小敏,等.刺梨、蜂胶、山楂口服液的降血脂功能研究[J].现代食品科技,2019,35(8):78-83,72.
[3] 黄晓其,吴晓丽,颜思珊,等.蜂胶对Triton-WR1339所致高脂血症小鼠的降脂作用及调控脂质代谢机质[J].南方医科大学学报,2018,38(8):1020-1025.
[4] NIE J R, CHANG Y N, LI Y J, et al.Caffeic acid phenethyl ester (Propolis extract) ameliorates insulin resistance by inhibiting JNK and NF-κB inflammatory pathways in diabetic mice and HepG2 cell models[J]. Journal of agricultural and food chemistry,2017, 65(41):9041-9053.
[5] 张磊,王世娇,王和生,等.何首乌有效组分对调节胆固醇代谢作用的配伍研究[J].时珍国医国药, 2019, 30(1): 43-45.
[6] WAN H, TIAN Y F, JIANG H P, et al.A NMR-based drug screening strategy for discovering active substances from herbal medicines: Using Radix Polygoni Multiflori as example[J].Journal of ethnopharmacology,2020,254:112712.
[7] LI N,ZHEN Z,MAO X J, et al.Effects of lipid regulation using raw and processed radix polygoni multiflori in rats fed a high-fat diet[J].Evidence based complementary & alternative medicine,2012,2012:329171.
[8] 李娜. 何首乌降脂作用及其主要成分体外吸收的研究[D].昆明:云南中医学院,2012.
[9] 毕倩. 基于肠道微生态调节的制何首乌干预胰岛素抵抗作用及机制研究[D].昆明:云南中医学院,2018.
[10] 魏佳迪. 基于代谢组学的滇黄精抗脂代谢紊乱作用机制研究[D].昆明:云南中医学院,2018.
[11] 王曦. 基于线粒体功能调节的滇黄精缓解非酒精性脂肪肝药效及机制探究[D].昆明:云南中医药大学,2019.
[12] 董金材. miRNA在滇黄精改善脂代谢紊乱中的作用研究[D].昆明:云南中医药大学,2019.
[13] GU W, WANG Y F, ZENG L X, et al.Polysaccharides from Polygonatum kingianum improve glucose and lipid metabolism in rats fed a high fat diet[J].Biomedicine & pharmacotherapy,2020,125(109910).
[14] YAN H L, LU J M, WANG Y F, et al.Intake of total saponins and polysaccharides from Polygonatum kingianum affects the gut microbiota in diabetic rats[J].Phytomedicine,2017,26(45).
[15] LI S, JIN S N, SONG C W, et al.The metabolic change of serum lysophosphatidylcholines involved in the lipid lowering effect of triterpenes from Alismatis rhizoma on high-fat diet induced hyperlipidemia mice[J].Journal of ethnopharmacology,2016,177(10-18).
[16] LI S, WANG L, DU Z F, et al.Identification of the lipid-lowering component of triterpenes from Alismatis rhizoma based on the MRM-based characteristic chemical profiles and support vector machine model[J].Analytical and bioanalytical chemistry,2019,411:3257-3268
[17] 丁琛一. 泽泻对GK大鼠糖尿病治疗效果的评价[D].杭州:浙江大学,2015.
[18] 张伟云,刘华欣,王青,等.23-乙酰泽泻醇B对2型糖尿病小鼠血糖的影响[J].中国药理学通报,2019,35(5):639-643.
[19] 於小波,昝俊峰,王金波,等.我国茯苓药材主要产区资源调查[J].时珍国医国药, 2011, 22(3): 714-716.
[20] 马克坚. 将云茯苓产品开发列入云南重点产业推进发展的思考[A]. 第三届兰茂论坛暨2016年云南省中医药界学术年会论文集[C].第三届兰茂论坛暨2016年云南省中医药界学术年会.云南,2016.
[21] 邓桃妹,彭代银,俞年军,等.茯苓化学成分和药理作用研究进展及质量标志物的预测分析[J].中草药,2020,51(10):2703-2717.
[22] KIM J H, SIM H A, JUNG D Y, et al.Poria cocus wolf extract ameliorates hepatic steatosis through regulation of lipid metabolism, inhibition of er stress, and activation of autophagy via AMPK activation[J].International journal of molecular sciences,2019,20(19):E4801.
[23] 楼招欢,程斌,夏伯侯,等.荷叶对高糖高脂饮食诱导的实验性非酒精性脂肪肝的作用研究[J].中华中医药杂志,2017,32(5):2169-2173.
[24] LI X, GUO J T, LIANG N, et al.6-Gingerol regulates hepatic cholesterol metabolism by up-regulation of LDLR and cholesterol efflux-related genes in HepG2 cells[J]. Frontiers in pharmacology,2018,9:159.
[25] CHANG H Y, WU J R, GAO W Y, et al.The cholesterol-modulating effect of methanol extract of pigeon pea (Cajanus cajan (L.) Millsp.) leaves on regulating LDLR and PCSK9 expression in HepG2 cells[J].Molecules,2019,24(3):493.
[26] CAO S J, XU P X, YAN J K, et al.Berberrubine and its analog, hydroxypropyl‐berberrubine, regulate LDLR and PCSK9 expression via the ERK signal pathway to exert cholesterol-lowering effects in human hepatoma HepG2 cells[J].Journal of cellular biochemistry,2019,120(2):1340-1349.
[27] LI L, FAN M L, LI Y N, et al.A rapid strategy for screening high-efficiency PCSK9 inhibitors from Ginkgo biloba leaves by ligand fishing, HPLC-Q-TOF-MS and interdisciplinary assay[J]. Journal of food and drug analysis,2020,28(2):273-282.
[28] SHEN Y B, YANG S N, HU X Y, et al.Natural product puerarin activates Akt and ameliorates glucose and lipid metabolism dysfunction in hepatic cells[J]. Journal of functional foods,2019,55:296-304.
[29] 吴娟. 乌榄降脂有效部位的筛选及其活性初步探究[D].广州:广东药科大学, 2018.
[30] WANG Q, MU R F, LIU X, et al.Steaming Changes the composition of Saponins of Panax notoginseng (Burk.) F.H. Chen that function in treatment of hyperlipidemia and obesity[J]. Journal of agricultural and food chemistry,2020,68(17):4865-4875.
[31] 陈帅,袁崇均,罗森,等.槐角黄酮衍生物制备工艺及其降脂作用研究[J].中药药理与临床,2018,34(6):50-54.
[32] LEE S E,LIM C Y,LIM S Y,et al.Effect of Ephedrae Herba methanol extract on high-fat diet-induced hyperlipidaemic mice[J].Pharmaceutical biology,2019,57(1):676-683.
[33] LIU M, WU K, MAO X Q, et al.Astragalus polysaccharide improves insulin sensitivity in KKAy mice: Regulation of PKB/GLUT4 signaling in skeletal muscle[J].Journal of ethnopharmacology,2010,127(1):32-37.
[34] JUAN Y C,KUO Y H,CHANG C C, et al.Administration of a decoction of sucrose- and polysaccharide-rich radix astragali (Huang Qi) ameliorated insulin resistance and fatty liver but affected beta-cell function in type 2 diabetic rats[J].Evidence-based complementary and alternative medicine,2011,2011:349807.
[35] 吴晶魁, 杨乔.中药水蛭对高脂血症大鼠脂质代谢及肝脏的影响[J].中国中药杂志,2018,43(4):794-799.
[36] 吴培赛,石松利,程向晖,等.蒙古扁桃药材不同提取物对高脂血症大鼠肝脏保护作用及机理的研究[J].中华中医药学刊,2017,35(2):295-298, 514.
[37] 赵云山,吴培赛,张慧文,等.蒙古扁桃药材正丁醇提取物降血脂作用的量效关系及其化学成分的研究[J].食品工业科技,2017,38(3):348-352.
[38] 郭晶. 川牛膝苦味的药理学评价研究[D].哈尔滨:黑龙江中医药大学,2016.
[39] 孙乐,贺震旦,杨润梅,等.粗壮女贞总苷降脂作用及其基于AMPK通路的降脂作用机制研究[J].中国药理学通报,2017, 33(8):1073-1079.
[40] 张紫文,李晨晨,潘瑞乐,等.基于蛋白质组学探讨粗壮女贞总苷对高脂血症金黄地鼠的调脂作用机制[J].中国药理学通报,2019,35(8):1126-1133.
[41] 张震. 土鳖虫抗高胆固醇血症模型内参基因筛选及分子机制研究[D].哈尔滨:东北农业大学,2019.
[42] XU J, LIAN F M, ZHAO L H, et al.Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula[J].Isme journal,2015,9(3):552-562.
[43] CHEN G, YANG X P, YANG X Y, et al.Jia-Wei-Jiao-Tai-Wan ameliorates type 2 diabetes by improving β cell function and reducing insulin resistance in diabetic rats[J].Bmc complementary and alternative medicine,2017,17(1):507.
[44] ZHUO J C, CAI D K, XIE K F, et al. Mechanism of YLTZ on glycolipid metabolism based on UPLC/TOF/MS metabolomics[J]. Journal of chromatography. B, analytical technologies in the biomedical and life sciences,2018,1097-1098:128-141.
[45] LIU J, LI Z Q, LIU H, et al.Metabolomics-based clinical efficacy and effect on the endogenous metabolites of Tangzhiqing Tablet, a Chinese patent medicine for type 2 diabetes mellitus with Hypertriglyceridemia[J].Evidence based complementary & alternative medicine,2018,2018:5490491.
[46] 王颖. 血脂灵片对高脂血症模型大鼠降血脂作用的实验研究[J].长春中医药大学学报,2011,27(1):8-9, 140.
[47] 王鹏,高敏艳,高岚,等.血脂灵片对脂肪酸合酶的体外抑制作用[J].中国实验方剂学杂志,2013,19(1):180-183.
[48] GONG G W, HAN G Y, HE H, et al.An ancient Chinese herbal decoction containing Angelicae Sinensis Radix, Astragali Radix, Jujuba Fructus,and Zingiberis Rhizoma recens stimulates the browning conversion of white adipocyte in cultured 3T3-L1 cells[J].Evidence based complementary & alternative medicine,2019,2019:3648685.
[49] YANG X P, LI L L, FANG K, et al.Wu-Mei-Wan reduces insulin resistance via inhibition of NLRP3 inflammasome activation in HepG2 cells[J].Evidence based complementary & alternative medicine,2017,2017:7283241.
[50] 史丽伟. 新消渴方调控AMPK信号通路改善2型糖尿病肝脏胰岛素抵抗的机制研究[D].北京:中国中医科学院,2019.
[51] 张亚楠. 山芪降糖颗粒的开发研究[D].长春:吉林大学,2018.
[52] 沈彦龙. 降糖益津胶囊的质量控制及降血糖活性研究[D]长春:吉林农业大学,2016.
[53] 田金英,周莹,陈玲,等.中药新配方景丹胰敏剂治疗代谢综合征的方剂研究[J].中国中药杂志,2016,41(2):272-278.
[54] FENG Y, CHEN Y, YANG B R, et al.Hepatoprotective effect of Jianpi Huoxue Formula on nonalcoholic fatty liver disease induced by methionine-choline-deficient diet in rat[J].Biomed research international,2019(1):1-12.
[55] GOU X J, GAO S S, CHEN L, et al.A metabolomic study on the intervention of traditional Chinese medicine Qushi Huayu Decoction on rat model of fatty liver induced by high-fat diet[J].Biomed research international,2019(14):1-14.
[56] 刘跃钧,朱虹,蒋燕锋,等.复方多花黄精混合提取物的降血脂作用[J].食品工业科技,2019,40(6):285-288, 293.
[57] 韩雪,张睦清,王茜,等.泽泻汤对高脂血症大鼠LXRα和ABCA1表达的影响[J].中华中医药学刊,2017,35(12):3107-3109.
[58] 杨静云. 山楂、泽泻、决明子与红曲霉混合发酵制备降脂中药的研究[D].成都:西南交通大学,2016.
[59] 杨静,江伟,苏剑锋.活血降脂保肝汤对NAFLD大鼠肝组织MTPmRNA及蛋白表达的影响[J].中国实验方剂学杂志,2016,22(6):109-113.
[60] YAN Z H,WU H, ZHOU H K, et al.Integrated metabolomics and gut microbiome to the effects and mechanisms of naoxintong capsule on type 2 diabetes in rats[J].Scientific reports,2020,10(1):10829.
[61] 李建良. 基于“清浊生华”理论的蒙药五味清浊散抗高脂血症的作用机制初探[D].北京:中国中医科学院,2019.
[62] 邰艳妮,翁艳鸿,张苏萍,等.一测多评法测定不同等级泽泻药材中7个萜类成分的含量[J].中国中药杂志,2019,44(11):2292-2307.
[63] HUANG X Y,GUO X L, LUO H L, et al.Fast differential analysis of propolis using surface desorption atmospheric pressure chemical ionization mass spectrometry[J].International journal of analytical chemistry,2015,2015:176475
[64] 田双双,赵晓梅,刘珊珊,等.基于UPLC特征图谱及萜类成分含量测定的泽泻产地差异研究[J].中国中药杂志,2020,45(7):1545-1557.
[65] 刘昌孝,陈士林,肖小河,等.中药质量标志物(Q-Marker):中药产品质量控制的新概念[J].中草药,2016,47(9):1443-1457.
[66] LIAO M L, SHANG H H, LI Y Z, et al.An integrated approach to uncover quality marker underlying the effects of Alisma orientale on lipid metabolism, using chemical analysis and network pharmacology[J].Phytomedicine,2018,45:93-104.
[67] 陈昭,张靖年,胥爱丽,等.基于UHPLC-MS-MS大通量分析的蜂胶影响PXR/CYP3A4调控血脂质量标志物筛选和评价[J].中草药,2020,51(3):662-668.
[68] LI Z Q, LIU J, ZHANG D Q, et al.Nuciferine and paeoniflorin can be quality markers of Tangzhiqing tablet, a Chinese traditional patent medicine, based on the qualitative, quantitative and dose-exposure-response analysis[J].Phytomedicine,2018,44:155-163.
[69] NIE C H, ZHANG F G, MA X W, et al.Determination of quality markers of Xuezhiling tablet for hyperlipidemia treatment[J].Phytomedicine,2018,44:231-238.
[70] CHEN Z, SUN D M, BI X L, et al.Selection and evaluation of quality markers from Yinlan capsule and its LXRα-mediated therapy for hyperlipidemia[J].Phytomedicine, 2019, 59: 152896.